[HTML][HTML] Increasing diversity in clinical trials: overcoming critical barriers

LT Clark, L Watkins, IL Piña, M Elmer… - Current problems in …, 2019 - Elsevier
Clinical trial results provide the critical evidence base for evaluating the safety and efficacy
of new medicines and medical products. Efficacy and safety may differ among population …

Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy

KI Alcaraz, TL Wiedt, EC Daniels… - CA: a cancer journal …, 2020 - Wiley Online Library
Although cancer mortality rates declined in the United States in recent decades, some
populations experienced little benefit from advances in cancer prevention, early detection …

Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation

JM Unger, R Vaidya, DL Hershman… - JNCI: Journal of the …, 2019 - academic.oup.com
Background Barriers to cancer clinical trial participation have been the subject of frequent
study, but the rate of trial participation has not changed substantially over time. Studies often …

Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018

JM Loree, S Anand, A Dasari, JM Unger… - JAMA …, 2019 - jamanetwork.com
Importance Representative racial/ethnic participation in research, especially in clinical trials
that establish standards of care, is necessary to minimize disparities in outcomes and to …

Patient-clinician communication: American Society of Clinical Oncology consensus guideline

T Gilligan, N Coyle, RM Frankel, DL Berry… - Journal of Clinical …, 2017 - ascopubs.org
Purpose To provide guidance to oncology clinicians on how to use effective communication
to optimize the patient-clinician relationship, patient and clinician well-being, and family well …

“When offered to participate”: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials

JM Unger, DL Hershman, C Till… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Patient participation in clinical trials is vital for knowledge advancement and
outcomes improvement. Few adult cancer patients participate in trials. Although patient …

[HTML][HTML] Comparing two sampling methods to engage hard-to-reach communities in research priority setting

MA Valerio, N Rodriguez, P Winkler, J Lopez… - BMC medical research …, 2016 - Springer
Background Effective community-partnered and patient-centered outcomes research needs
to address community priorities. However, optimal sampling methods to engage …

The role of clinical trial participation in cancer research: barriers, evidence, and strategies

JM Unger, E Cook, E Tai, A Bleyer - American Society of Clinical …, 2016 - ascopubs.org
Fewer than one in 20 adult patients with cancer enroll in cancer clinical trials. Although
barriers to trial participation have been the subject of frequent study, the rate of trial …

[HTML][HTML] Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups

B Bonevski, M Randell, C Paul, K Chapman… - BMC medical research …, 2014 - Springer
Background This study aims to review the literature regarding the barriers to sampling,
recruitment, participation, and retention of members of socioeconomically disadvantaged …

Normal cognitive aging

CN Harada, MCN Love… - Clinics in geriatric …, 2013 - geriatric.theclinics.com
Normal Cognitive Aging - Clinics in Geriatric Medicine Skip to Main Content Advertisement
Clinics in Geriatric Medicine Log in Register Log in Subscribe Claim Cart (3 items)3 Skip menu …